What are the opening hours?

Monday 09:00 - 18:00 Tuesday 09:00 - 18:00 Wednesday 09:00 - 18:00 Thursday 09:00 - 18:00 Friday 09:00 - 18:00

Oncode Scientific Sdn Bhd

Home
Malaysia
Shah Alam
Oncode Scientific Sdn Bhd

Call Directions Website Contact the practice

Oncode Scientific Sdn Bhd
201501029484 (1154805-X)

Leading the Precision Medicine Revolution in Asia

Since 2015, Oncode Scientific Sdn Bhd has emerged as a trailblazer in the realm of precision medicine, setting new benchmarks in cancer molecular diagnostics. Our multidisciplinary team, comprising top-tier experts from molecular science and clinical practice, brings together decades of experience in medical diagnostics and research. At our cutting-edge facilities in Malaysia, we spearhead one of Asia’s most pioneering precision medicine initiatives, specializing in both solid tumors and hematologic cancers. Our relentless pursuit of innovation drives us to constantly challenge the status quo, exceeding clinical and diagnostic standards to deliver groundbreaking medical solutions. Oncode is dedicated to transforming healthcare—advancing disease prevention, early detection, and targeted intervention. With a commitment to excellence, we provide world-class molecular diagnostic services that are both accessible and revolutionary, empowering the global community to embrace the full potential of precision medicine.

12/10/2026

𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐭𝐚𝐥𝐞𝐧𝐭𝐬. 𝐀 𝐬𝐡𝐚𝐫𝐞𝐝 𝐩𝐮𝐫𝐩𝐨𝐬𝐞. 𝐘𝐨𝐮𝐫 𝐧𝐞𝐱𝐭 𝐜𝐡𝐚𝐩𝐭𝐞𝐫 𝐚𝐭 𝐎𝐧𝐜𝐨𝐝𝐞 💙

Great work starts with people—those who ask questions, bring ideas and care about what they do.

At 𝐎𝐧𝐜𝐨𝐝𝐞, we’re looking for new colleagues across science, business, communications and administration. If you’re ready to put your strengths to work and contribute to a team, we’d love to get to know you.

Find your opportunity:
• 𝐀𝐝𝐦𝐢𝐧 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭
• 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭 𝐅𝐢𝐧𝐚𝐧𝐜𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐫
• 𝐅𝐢𝐧𝐚𝐧𝐜𝐞 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞
• 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 & 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞
• 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞
• 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞
• 𝐑&𝐃 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭
• 𝐑&𝐃 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭 (𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬)

Whether you enjoy solving scientific challenges, building connections, telling stories or keeping things running smoothly, explore our openings to see where your skills could take you.

📩 𝐓𝐚𝐤𝐞 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐬𝐭𝐞𝐩—𝐚𝐩𝐩𝐥𝐲 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐭𝐡𝐞 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐥𝐢𝐧𝐤 𝐨𝐫 𝐬𝐜𝐚𝐧 𝐭𝐡𝐞 𝐐𝐑 𝐜𝐨𝐝𝐞 𝐨𝐧 𝐭𝐡𝐞 𝐩𝐨𝐬𝐭𝐞𝐫𝐬 𝐍𝐎𝐖.

Your experience matters. Your ideas matter. We look forward to hearing your story.

Know someone who would be a great fit? Share this post with them.

✔ Priority will be given to Malaysia-based candidates.
✔ Only shortlisted candidates will be contacted.

#𝑾𝒆𝑨𝒓𝒆𝑯𝒊𝒓𝒊𝒏𝒈𝑭𝒐𝒓𝑭𝒖𝒍𝒍𝑻𝒊𝒎𝒆𝑷𝒐𝒔𝒊𝒕𝒊𝒐𝒏𝒔 #𝙅𝙤𝙞𝙣𝙊𝙪𝙧𝙏𝙚𝙖𝙢 #𝗖𝗮𝗿𝗲𝗲𝗿𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 #𝗺𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗷𝗼𝗯𝘀

08/10/2026

While precise anatomical margins remain the cornerstone in breast and endocrine surgery, comprehensive molecular profiling now adds a vital layer of insight to patient care.

On 25–26 September 2026, the Oncode team connected with Malaysia’s leading surgeons & fellows at the 𝗕𝗿𝗲𝗮𝘀𝘁 𝗮𝗻𝗱 𝗘𝗻𝗱𝗼𝗰𝗿𝗶𝗻𝗲 𝗙𝗲𝗹𝗹𝗼𝘄𝘀𝗵𝗶𝗽 𝗦𝗲𝗺𝗶𝗻𝗮𝗿 𝟮𝟬𝟮𝟲 in Pahang. Organised by the Persatuan Pembedahan Payudara dan Endokrin Malaysia (MyBESS), the event highlighted evolving approaches to patient management.

Across our discussions, one theme was clear: molecular testing is increasingly fundamental to clinical decision-making. From evaluating indeterminate nodules and supporting surgical planning, to guiding targeted therapies and hereditary risk stratification, these insights help guide highly personalised care.

To translate complex molecular data into clinical utility, Oncode’s accredited NGS and PCR tests deliver:

• 𝗔𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗣𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴: Rapid identification of critical genetic alterations (e.g., 𝘉𝘙𝘊𝘈1, 𝘉𝘙𝘊𝘈2, 𝘗𝘐𝘒3𝘊𝘈, 𝘌𝘚𝘙1, 𝘉𝘙𝘈𝘍 V600E) to guide targeted therapy and surgical scope.
• 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗖𝗼𝘂𝗻𝘀𝗲𝗹𝗹𝗶𝗻𝗴: Dedicated support to help surgeons and patients navigate germline findings.
• 𝗢𝗽𝘁𝗶𝗺𝗶𝘀𝗲𝗱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗬𝗶𝗲𝗹𝗱: Validated through rigorous, yearly external quality assurance programmes.
• 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗪𝗼𝗿𝗸𝗳𝗹𝗼𝘄: Delivering comprehensive genomic insights within practical turnaround times.

Curative surgery demands uncompromising diagnostic clarity. We are proud to advance this standard of precision medicine alongside MyBESS and the next generation of surgical leaders.

29/09/2026

𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗖𝗮𝗻𝗰𝗲𝗿: 𝗧𝗵𝗲 #𝟯 𝗖𝗮𝗻𝗰𝗲𝗿 𝗶𝗻 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗻 𝗠𝗲𝗻.

𝟭 𝗶𝗻 𝟴𝟯 𝗺𝗲𝗻 will face a prostate cancer diagnosis in their lifetime—it could be a father, a brother, a partner, or a friend.

Prostate cancer is known to show few early symptoms, making awareness and early screening critical. The statistics speak for themselves:

✅ 𝗖𝗮𝘂𝗴𝗵𝘁 𝗘𝗮𝗿𝗹𝘆: 97% 5-year relative survival rate
⚠️ 𝗖𝗮𝘂𝗴𝗵𝘁 𝗟𝗮𝘁𝗲: Drops significantly to 43%

Proactive health choices save lives. Whether starting with a simple, routine PSA blood test or exploring advanced options like genetic testing for those with a strong family history, taking action early makes all the difference.

📲 𝗧𝗮𝗸𝗲 𝗰𝗵𝗮𝗿𝗴𝗲 𝗼𝗳 𝘆𝗼𝘂𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 𝘁𝗼𝗱𝗮𝘆: Scan the QR code or click the link below to learn more about genetic risk testing and counselling.
https://www.oncodesc.com

25/09/2026

Every successful targeted therapy relies on absolute diagnostic clarity. 💡

Oncode was honoured to partner with 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗦𝘂𝗹𝘁𝗮𝗻 𝗜𝘀𝗺𝗮𝗶𝗹 at the 𝟳𝘁𝗵 𝗚𝘆𝗻𝗮𝗲𝗰𝗼𝗹𝗼𝗴𝗶𝗰 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗧𝗿𝗮𝗶𝗻𝗲𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 on 𝟭𝟴–𝟭𝟵 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲.

A special thank you to 𝗗𝗿. 𝗖𝗵𝗲𝗻 𝗠𝗮𝘆 𝗙𝗲𝗻𝗴, Consultant Clinical Oncologist at Hospital Sultan Ismail, for leading an incisive clinical session titled:

📌 "𝘗𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦 𝘪𝘯 𝘎𝘺𝘯𝘢𝘦𝘤𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘊𝘢𝘯𝘤𝘦𝘳𝘴: 𝘛𝘩𝘦 𝘙𝘰𝘭𝘦 𝘰𝘧 𝘕𝘦𝘹𝘵-𝘎𝘦𝘯𝘦𝘳𝘢𝘵𝘪𝘰𝘯 𝘚𝘦𝘲𝘶𝘦𝘯𝘤𝘪𝘯𝘨 (𝘕𝘎𝘚) 𝘢𝘯𝘥 𝘏𝘰𝘮𝘰𝘭𝘰𝘨𝘰𝘶𝘴 𝘙𝘦𝘤𝘰𝘮𝘣𝘪𝘯𝘢𝘵𝘪𝘰𝘯 𝘋𝘦𝘧𝘪𝘤𝘪𝘦𝘯𝘤𝘺 (𝘏𝘙𝘋) 𝘛𝘦𝘴𝘵𝘪𝘯𝘨"

For over 11 years, Oncode has provided clinicians across Malaysia with accredited, high-precision NGS and PCR panels for gynaecological malignancies. By integrating advanced HRD testing, 𝘗𝘖𝘓𝘌/𝘛𝘗53 subtyping, and germline risk assessment—backed by rigorous international External Quality Assurance (EQA) programmes—our assays deliver the analytical depth required to confidently guide targeted maintenance therapies.

Conferences like this bridge the gap between complex genomic data and real-world clinical decisions—ensuring modern diagnostics directly translate into better patient care.

We extend our sincere gratitude to the organizers and participants for driving meaningful dialogue and pushing the boundaries of precision care in gynaecological oncology.

16/09/2026

𝘛𝘩𝘦 𝘵𝘳𝘶𝘦 𝘮𝘦𝘢𝘴𝘶𝘳𝘦 𝘰𝘧 𝘢 𝘯𝘢𝘵𝘪𝘰𝘯’𝘴 𝘱𝘳𝘰𝘨𝘳𝘦𝘴𝘴 𝘪𝘴 𝘯𝘰𝘵 𝘧𝘰𝘶𝘯𝘥 𝘪𝘯 𝘪𝘵𝘴 𝘵𝘰𝘸𝘦𝘳𝘪𝘯𝘨 𝘴𝘬𝘺𝘭𝘪𝘯𝘦, 𝘣𝘶𝘵 𝘪𝘯 𝘵𝘩𝘦 𝘦𝘯𝘥𝘶𝘳𝘪𝘯𝘨 𝘷𝘪𝘵𝘢𝘭𝘪𝘵𝘺 𝘰𝘧 𝘪𝘵𝘴 𝘱𝘦𝘰𝘱𝘭𝘦. ✨

For over 11 years, 𝗢𝗻𝗰𝗼𝗱𝗲 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 has had the profound privilege of supporting clinicians and families across Malaysia. At the core of every molecular diagnostic report is a shared purpose: equipping healthcare professionals with definitive diagnostic clarity and providing families with a clear path forward.

By advancing the frontiers of oncology and molecular diagnostics, our commitment extends far beyond genomic sequencing—we are actively shaping a healthier, better-informed future for the nation.

𝗛𝗮𝗽𝗽𝘆 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮 𝗗𝗮𝘆! Here is to a shared vision of health, innovation, and a stronger tomorrow for all.

11/09/2026

In lung cancer diagnostics, every precious tissue section matters. But it’s the 𝘤𝘰𝘮𝘱𝘭𝘦𝘵𝘦 genomic story that truly changes a patient's life.

The Oncode Team recently had the privilege of joining the Department of Respiratory Medicine at 𝗦𝘂𝗹𝘁𝗮𝗻 𝗜𝗱𝗿𝗶𝘀 𝗦𝗵𝗮𝗵 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹, 𝗦𝗲𝗿𝗱𝗮𝗻𝗴 for an insightful Continuing Medical Education (CME) on 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗹𝘂𝗻𝗴 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗮𝗿𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝘁𝗲𝘀𝘁𝗶𝗻𝗴.

Cutting through the noise, we discussed the realities of modern molecular diagnostics:

🧬 𝗛𝗼𝘁𝘀𝗽𝗼𝘁 𝘃𝘀. 𝗙𝘂𝗹𝗹-𝗘𝘅𝗼𝗻 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲: Why full-exon NGS discovery is the new standard over traditional PCR and hotspot NGS panels, ensuring critical genetic alterations (such as 𝘌𝘎𝘍𝘙, 𝘈𝘓𝘒, 𝘙𝘖𝘚1, 𝘒𝘙𝘈𝘚, 𝘔𝘌𝘛, and 𝘙𝘌𝘛) are never missed.

🩸 𝗦𝗼𝗹𝗶𝗱 𝗧𝘂𝗺𝗼𝘂𝗿 & 𝗟𝗶𝗾𝘂𝗶𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀: Demonstrating Oncode’s specialised lung cancer repertoire—from tissue biopsy solid tumour panels to non-invasive liquid biopsies—ensuring no patient is left without actionable genomic insights, even when tissue is insufficient.

⏱️ 𝗠𝗮𝘅𝗶𝗺𝗶𝘀𝗶𝗻𝗴 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗬𝗶𝗲𝗹𝗱: Optimising sample utilisation and workflow efficiency so clinicians can move from diagnosis to personalised treatment plans with absolute confidence.

A heartfelt thank you to the Department of Respiratory Medicine at Sultan Idris Shah Hospital, Serdang for their warm hospitality and dedication to advancing precision lung cancer care.

31/08/2026

𝗧𝗿𝘂𝗲 𝗳𝗿𝗲𝗲𝗱𝗼𝗺 𝗯𝗲𝗴𝗶𝗻𝘀 𝘄𝗶𝘁𝗵 𝗵𝗲𝗮𝗹𝘁𝗵.

As we celebrate our nation’s 69th year of independence, we reflect on how far we've come—and where we are going. At 𝗢𝗻𝗰𝗼𝗱𝗲, our 11-year commitment to precision medicine has always been driven by one simple goal: 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝗮 𝗯𝗲𝘁𝘁𝗲𝗿 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄.

Clarity through science. Early and precise detection empowers informed healthcare decisions, giving you true control over your future.

Here’s to 69 years of progress and a healthier Malaysia.

𝗦𝗲𝗹𝗮𝗺𝗮𝘁 𝗛𝗮𝗿𝗶 𝗠𝗲𝗿𝗱𝗲𝗸𝗮! ✨

25/08/2026

𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲: 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗠𝗕𝗖𝗦 𝟮𝟬𝟮𝟲 🎗️

Behind every genomic sequence we analyse at Oncode is a patient seeking clarity and a clinician determining the best path forward.

Reflecting on an incredible experience at the 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮𝗻 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟲 𝗼𝗻 𝟭𝟱–𝟭𝟲 𝗔𝘂𝗴𝘂𝘀𝘁 𝗶𝗻 𝗞𝘂𝗮𝗹𝗮 𝗟𝘂𝗺𝗽𝘂𝗿, this year’s summit brought together Malaysia’s leading oncologists, breast surgeons, genetic counsellors, policymakers, patients, survivors, and advocates—all pushing awareness and elevating support for breast cancer care.

From assessing hereditary germline risk to guiding targeted therapy paths, connecting with dedicated clinicians, patient advocates, and survivors at MBCS 2026 reinforced why diagnostic precision matters so deeply.

When treatment decisions carry this much weight, certainty changes everything.

From deep-dive case discussions with clinicians to heartfelt conversations with patients and survivors asking about hereditary risk, our booth was alive with purpose. Thank you for bringing your clinical challenges, your curiosity, and your passion for patient care to our team.

20/08/2026

𝗖𝗹𝗼𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗚𝗮𝗽 𝗶𝗻 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆🎯

Every targeted therapy decision begins with molecular clarity. At Oncode, we champion comprehensive profiling—delivering globally accredited, high-precision assays that maximise the diagnostic value of every patient sample.

On 13 August 2026, Oncode had the privilege of conducting a Continuing Medical Education (CME) session at the 𝗗𝗲𝗽𝗮𝗿𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗠𝗮𝗹𝗮𝘆𝗮 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗲𝗻𝘁𝗿𝗲 (𝗨𝗠𝗠𝗖), titled:

📌 "𝗖𝗹𝗼𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗚𝗮𝗽: 𝗠𝗮𝘅𝗶𝗺𝗶𝘀𝗶𝗻𝗴 𝗡𝗚𝗦 𝗠𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗣𝗿𝗲𝗰𝗶𝘀𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗠𝗮𝘁𝗰𝗵𝗶𝗻𝗴"

During the session, our team engaged in insightful discussions with UMMC’s oncology team on:

🔬 𝗠𝗮𝘅𝗶𝗺𝗶𝘀𝗶𝗻𝗴 𝗡𝗚𝗦 𝗬𝗶𝗲𝗹𝗱: Enhancing variant detection sensitivity across comprehensive gene targets by demonstrating the critical diagnostic differences between targeted hotspot panels and full-exon NGS profiling.
🧬 𝗔𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗠𝗮𝘁𝗰𝗵𝗶𝗻𝗴: Translating complex genomic profiles (EGFR, BRCA1 & BRCA2, PIK3CA, ESR1, etc.) into clear, actionable treatment pathways.
🏥 𝗘𝘅𝗽𝗲𝗿𝘁 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘂𝗽𝗽𝗼𝗿𝘁: Supporting hereditary cancer risk assessment with dedicated multilingual consultations by Oncode’s clinical geneticists and genetic counsellors.

A heartfelt thank you to the Department of Clinical Oncology at UMMC for the warm welcome and engaging discussion. We look forward to our next opportunity to connect!

🌐 Learn more about our accredited genomic profiling solutions: www.oncodesc.com

19/08/2026

𝗦𝗲𝗹𝗳-𝗰𝗮𝗿𝗲 𝗶𝘀𝗻'𝘁 𝘀𝗲𝗹𝗳𝗶𝘀𝗵, 𝗶𝘁'𝘀 𝘁𝗮𝗸𝗶𝗻𝗴 𝗰𝗼𝗻𝘁𝗿𝗼𝗹 𝗼𝗳 𝘆𝗼𝘂𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘁𝗼𝗿𝘆. 🌸

In the hustle of building careers, raising families, and managing daily life, it is far too easy to write off severe fatigue, nagging pain, or subtle body shifts as "just being busy”.

𝟭 𝗶𝗻 𝟴 Malaysian women will face a cancer diagnosis in their lifetime. Tragically, national data shows that the vast majority of common female cancers—breast, colorectal, and lung—are caught in late stages (Stage III & IV).

Early warning signs are frequently shrugged off, or the disease progresses silently. But waiting for symptoms to force your hand takes away your most valuable asset: 𝘁𝗶𝗺𝗲.

Taking control of your health means shifting from reactive to proactive:

▪️𝗞𝗻𝗼𝘄 𝗬𝗼𝘂𝗿 𝗕𝗮𝘀𝗲𝗹𝗶𝗻𝗲: Pay attention to key body changes (including lumps, swelling, digestive shifts, unexplained bleeding, or a lingering cough) and discuss them early with your doctor.
▪️𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝘀𝗲 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴𝘀: Regular checkups catch disease at its most treatable stages long before severe symptoms appear.
▪️𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝗬𝗼𝘂𝗿 𝗚𝗲𝗻𝗲𝘀: If you have a strong family history of cancer, precision genetics can give you a roadmap.

Do not let a busy calendar or fear keep you from prioritising yourself. Talk to your doctor today to rule out underlying conditions. For women with a strong family history of cancer, speak with your doctor about Oncode Scientific’s comprehensive genetic risk testing and genetic counselling.

Address

Lot 03-01, 3rd Floor. Hap Seng Business Park, No. 12, Persiaran Perusahaan, Unity Square. Seksyen 23, Shah Alam D. E.
Shah Alam
40300

Opening Hours

Monday	09:00 - 18:00
Tuesday	09:00 - 18:00
Wednesday	09:00 - 18:00
Thursday	09:00 - 18:00
Friday	09:00 - 18:00

Telephone

+60333100819

Website

http://www.oncodesc.com/

Alerts

Be the first to know and let us send you an email when Oncode Scientific Sdn Bhd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Oncode Scientific Sdn Bhd:

Want your practice to be the top-listed clinic in Shah Alam?